Aug 20 (Reuters) - A federal judge ordered CVS Health's ( CVS )
pharmacy benefit manager unit to pay $289.9 million in
damages and penalties after it overcharged Medicare for
prescription drugs.
In a Tuesday decision, Chief Judge Mitchell Goldberg in
Philadelphia federal court tripled to $285 million the damages
he had ordered CVS Caremark to pay in June, citing the federal
False Claims Act. He added a $4.87 million civil fine.
Goldberg rejected CVS' request to pay less, saying that
while CVS Caremark was liable for only two years of overbilling,
evidence at trial "made clear that the fraud was financially
motivated, not the result of some innocent or mistaken belief."
CVS, based in Woonsocket, Rhode Island, said on Wednesday it
plans to appeal.
Last month, a Manhattan federal judge ordered CVS' Omnicare unit
to pay $948.8 million in a separate whistleblower lawsuit
alleging fraudulent billing. CVS plans to appeal that judgment.
Goldberg presided in March over a non-jury trial in the
whistleblower case brought by Sarah Behnke, a former head
actuary for Medicare Part D at Aetna.
She accused CVS Caremark of having caused health insurers
such as Aetna to submit inflated claims since 2010 to the
Centers for Medicare and Medicaid Services (CMS), while
pharmacies such as Rite Aid and Walgreens were paid
less.
CVS argued that the original $95 million in damages was
substantial, and punitive damages should be limited to $95
million.
But the judge said CVS Caremark's fraud not only financially
harmed the government, but diminished public confidence in it.
"CMS relies on companies like Caremark to truthfully and
accurately report Part D drug prices," he wrote. "Caremark's
conduct broke CMS's trust, and as a result, the public's trust
in CMS."
Behnke sued in 2014. CVS bought Aetna four years later.
The False Claims Act lets whistleblowers sue on behalf of
the government and share in recoveries, typically 15% to 30%.
The case is US ex rel Behnke v CVS Caremark Corp et al, U.S.
District Court, Eastern District of Pennsylvania, No. 14-00824.